Document Detail


Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost.
MedLine Citation:
PMID:  17283565     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The aim of this review was to compare the efficacy, safety, patient preference, and cost-effectiveness of once-daily budesonide aqueous nasal spray (BANS), fluticasone propionate nasal spray (FPNS), mometasone furoate nasal spray (MFNS), and triamcinolone aqueous nasal spray (TANS) for treatment of allergic rhinitis (AR) in adult patients. METHODS: A MEDLINE search (1966 to January 2004) was conducted to identify potentially relevant English language articles. Pertinent abstracts from recent allergy society meetings were identified also. The medical subject heading search terms included were intranasal corticosteroid (INS), nasal steroid, BANS, MFNS, FPNS, or TANS and AR. Selected studies were randomized, controlled, comparison trials of patients with AR treated with once-daily BANS, MFNS, FPNS, or TANS. RESULTS: All four INSs administered once daily were effective and well tolerated in the treatment of AR in adult patients, with similar efficacy and adverse event profiles. No differences were seen between INSs in systemic effects, except for significantly lower overnight urinary cortisol levels in healthy volunteers treated with FPNS compared with placebo. Based on sensory attributes, patients preferred BANS and TANS versus MFNS and FPNS. BANS was associated with more days of treatment per prescription at a lower cost per day for adults compared with the other INSs and is the only INS with a pregnancy category B rating. CONCLUSION: BANS, FPNS, MFNS, and TANS have similar efficacy and safety profiles. Differences in sensory attributes, documented safety during pregnancy, and cost may contribute to better patient acceptance of one INS versus another and promote better adherence to therapy.
Authors:
Howard Herman
Related Documents :
12732775 - Combination of laparoscopic bilateral uterine artery ligation and intraamniotic methotr...
11107525 - Methotrexate and the photodermatitis reactivation reaction: a case report and review of...
17978125 - Total laparoscopic hysterectomy for female-to-male transsexuals.
11056225 - Predictors of treatment failure for ectopic pregnancy treated with single-dose methotre...
8273605 - The corpus callosum: normal fetal development as shown by transvaginal sonography.
9018725 - The relationship between maternal birthweight and gestational age in twins and singleto...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  American journal of rhinology     Volume:  21     ISSN:  1050-6586     ISO Abbreviation:  Am J Rhinol     Publication Date:    2007 Jan-Feb
Date Detail:
Created Date:  2007-02-07     Completed Date:  2007-03-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8807268     Medline TA:  Am J Rhinol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  70-9     Citation Subset:  IM    
Affiliation:
ENT of Georgia, Riverdale, Georgia, USA. howardhh@bellsouth.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intranasal
Cost-Benefit Analysis
Dose-Response Relationship, Drug
Drug Administration Schedule
Glucocorticoids / administration & dosage*
Humans
Patient Satisfaction*
Rhinitis, Allergic, Perennial* / drug therapy,  economics,  psychology
Treatment Outcome
Chemical
Reg. No./Substance:
0/Glucocorticoids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Steroid injection for sinonasal polyps: the University of Virginia experience.
Next Document:  Indications for image-guided sinus surgery: the current evidence.